Global Coronary Stents Industry on Track to Achieve US$51.2 Million Valuation by 2032 with 5.1% CAGR, | According to FMI

The Global Coronary Stents Industry is on a trajectory to attain a significant valuation of US$ 51.2 million by the year 2032, exhibiting a steady compound annual growth rate (CAGR) of 5.1% from 2022 to 2032. In 2022, the market is expected to hit an estimated value of US$ 33.36 million.

The market’s growth is primarily attributed to the mounting geriatric population, the increasing prevalence of cardiovascular diseases, and the surge in lifestyle-related health issues, such as diabetes, obesity, and other medical conditions. This robust expansion of the coronary stents industry is anticipated throughout the forecast period.

Key drivers of this growth include the heightened awareness of the numerous advantages associated with stenting procedures. These procedures are known to lead to a significant improvement in blood flow and provide protection against further damage to the heart muscle, thereby contributing to the market’s remarkable progression. Moreover, stenting is instrumental in alleviating the symptoms of heart disease, including angina and shortness of breath, ultimately reducing the need for more invasive coronary bypass surgery. Consequently, both medical practitioners and patients are increasingly favoring stenting as it is minimally invasive and facilitates a relatively swift post-operative recovery period.

Get a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-1993

Furthermore, a rise in the global geriatric population is leading to a larger patient pool with serious cardiovascular diseases. Again, hypertension is arising as a grave public health concern. Obesity, too, adds to this burden as one of the primary risk factors accountable for different cardiovascular diseases worldwide.

Coronary stenting is prescribed to patients who are suffering from coronary artery blockage. Though angioplasty is the first line of treatment for patients with acute coronary artery blockages while the number of patients undergoing stenting has been increasing steadily over the last ten years. This is owing to the rise of outpatient coronary stenting procedures, which shortens long hospital stays. Additionally, a large number of cardiologists prescribing stenting procedures for patients with CAD is a prime factor that will likely fuel revenue growth of the coronary stent market during the forecast period.

“Increasing cases of lifestyle diseases like obesity and diabetes often result in heart issues which, in turn, supplements the global growth of the coronary stents industry over the forecast period,” says an FMI analyst.

Key Takeaways:

• Rising awareness of the benefits associated with stenting will strengthen market prospects.
• Prevalence of alternative treatment methods, product failure, and recalls are certain factors that may hamper market growth.
• Growing cases of coronary artery diseases propel the coronary stent market in the United States.
• Favorable government support for the healthcare sector will present new market opportunities in China.

Discovering the assumptions behind the study. Ask an Analyst Now.
https://www.futuremarketinsights.com/ask-question/rep-gb-1993

Competitive Landscape

Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medica among others are some of the major players in the coronary stents market profiled in the full version of the report.

Key market players are focusing on product upgradation and offering new features to meet the rising consumer demand. These organizations are employing strategies like new product releases, partnerships, collaborations, mergers, and acquisitions to gain a competitive advantage.

More Insights into Coronary Stents Industry Report

In its latest report, FMI offers an unbiased analysis of the global coronary stents industry, providing historical data from 2016 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of product type (drug eluting stent (DES), bare metal stent (BMS), bioresorbable vascular stent (BVS)), raw material (cobalt chromium, stainless steel, platinum-chromium, nickel-titanium, polymer), end user (hospitals, ambulatory surgical centers, cardiac catheterization laboratories), and region.

According to the latest FMI reports, based on region, China’s coronary stent market will likely exhibit an impressive growth rate during the observation period due to favorable government support for the healthcare sector. The coronary stent market in the United States is anticipated to demonstrate substantial growth over the forecast period. The rising prevalence of coronary artery disease is spurring the demand for interventional cardiology treatment in this country. Sedentary lifestyles, smoking, poor dietary habits, and pollution often contribute to increasing cases of cardiovascular diseases. All of these factors are expected to drive the demand for the target market during 2022-2032.

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-1993

Key Segments Covered in the Coronary Stents Industry Analysis

By Product:

• Drug Eluting Stent (DES)
• Bare Metal Stent (BMS)
• Bioresorbable Vascular Stent (BVS)

By Raw Material:

• Cobalt Chromium
• Stainless Steel
• Platinum – Chromium
• Nickel – Titanium
• Polymer

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube